ALFA Filings
Every announcement, straight from the exchange
Every Epigral board meeting date announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Epigral schedules a board meeting on November 2, 2026 to approve unaudited Q2 and half-year results ended September 30, 2026. The notice is issued for shareholder information.
Epigral Ltd scheduled a board meeting for July 27, 2026. The board will consider the company's first quarter unaudited financial results.
Epigral Limited has scheduled a Board Meeting for May 2, 2026, to approve audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also consider a final dividend recommendation. The trading window remains closed until May 4, 2026.
Epigral Ltd has scheduled a Board Meeting for May 2, 2026. The directors will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Additionally, the board will consider recommending a final dividend for the financial year.